Humana Inc. $HUM Shares Acquired by Atlatl Advisers LLC

Atlatl Advisers LLC lifted its stake in shares of Humana Inc. (NYSE:HUM) by 13.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,065 shares of the insurance provider’s stock after acquiring an additional 130 shares during the quarter. Atlatl Advisers LLC’s holdings in Humana were worth $260,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Cary Street Partners Investment Advisory LLC increased its stake in shares of Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after acquiring an additional 46 shares during the period. Zions Bancorporation National Association UT acquired a new position in Humana in the first quarter worth approximately $37,000. CVA Family Office LLC grew its position in Humana by 63.4% in the second quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock worth $54,000 after buying an additional 85 shares during the last quarter. Ransom Advisory Ltd acquired a new position in Humana in the first quarter worth approximately $66,000. Finally, Transamerica Financial Advisors LLC boosted its stake in Humana by 1,027.6% in the 1st quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock worth $87,000 after purchasing an additional 298 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Down 0.2%

Humana stock opened at $290.66 on Friday. The firm’s fifty day simple moving average is $281.65 and its 200-day simple moving average is $258.97. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $34.96 billion, a P/E ratio of 22.31, a P/E/G ratio of 1.70 and a beta of 0.42.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same quarter in the previous year, the firm posted $6.96 EPS. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. Sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Friday, September 26th. Humana’s payout ratio is 27.17%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on HUM shares. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Humana in a research note on Saturday. Barclays decreased their price objective on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a research note on Friday, October 3rd. Bank of America raised their price objective on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a research note on Friday, October 10th. Mizuho raised their price objective on shares of Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Finally, Sanford C. Bernstein lifted their target price on shares of Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Eight research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $297.58.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.